Comments
Glenmark Pharmaceuticals said on Friday that its subsidiary Glenmark Generics has entered into a settlement and licence agreement with US-based Nycomed to resolve patent infringement lawsuit for fluticasone propionate lotion, used for treating skin pain and itch.
“Glenmark Generics Ltd has entered into a settlement and licence agreement with Nycomed US to resolve the patent infringement suit regarding Glenmark's abbreviated new drug application for Fluticasone Propionate 0.05 lotion,” Glenmark said in a filing to the Bombay stock Exchange.
“Under the terms of agreement, Glenmark will be able to market and distribute its Fluticasone Propionate lotion under a royalty-bearing license from Nycomed US in March 2012, or earlier in certain circumstances,” it added.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.